SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $836,418 | +5.9% | 6,900 | 0.0% | 0.13% | +11.4% |
Q2 2023 | $790,188 | -16.9% | 6,900 | 0.0% | 0.11% | -22.4% |
Q1 2023 | $951,027 | +6.4% | 6,900 | 0.0% | 0.15% | +1.4% |
Q4 2022 | $894,102 | +17.2% | 6,900 | 0.0% | 0.14% | +10.7% |
Q3 2022 | $763,000 | +67.3% | 6,900 | +130.0% | 0.13% | +59.8% |
Q2 2019 | $456,000 | +91.6% | 3,000 | +50.0% | 0.08% | +90.7% |
Q1 2019 | $238,000 | -27.2% | 2,000 | -33.3% | 0.04% | -36.8% |
Q4 2018 | $327,000 | -32.6% | 3,000 | 0.0% | 0.07% | -18.1% |
Q3 2018 | $485,000 | +83.7% | 3,000 | +50.0% | 0.08% | +76.6% |
Q2 2018 | $264,000 | – | 2,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
TOBAM | 371,107 | $27,659,000 | 1.18% |
Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |